Alternatives to Enfusion

{"intro": "Enfusion brings front-to-back investment management to hedge funds and asset managers. It combines real-time positions, P&L, analytics, factor exposure and order generation with a native OEMS for equities, fixed income, options, futures, FX, swaps and other instruments. Compliance rules run during order creation, while shared IBOR and ABOR data, extensive instrument coverage and scenario-based risk analytics support portfolio oversight. FIX connectivity reaches more than 300 liquidity sources, with automated prime broker and custodian delivery.\n\nSwitching means balancing that institutional scope against practical constraints. Enfusion is paid with pricing on request, and clients provide the hardware, software and internet access needed to use it. Its supported access spans iOS, Linux, macOS, web and Windows. Alternatives may trade execution and compliance depth for free or lower-cost entry, tax-lot tracking, broader personal portfolio analysis, wealth-management accounting, client portals or Android access. Weigh the workflows your organization needs, the assets and strategies involved, and whether a simpler portfolio tool is sufficient.", "rows": [{"ref": "sw:stock-rover", "name": "Stock Rover", "best_for": "Investors wanting allocation, risk and tax-lot analysis", "pricing": "Free plan; paid from $29/mo (annual); 14-day trial", "key_difference": "Stock Rover focuses on multi-asset portfolio analysis and tax-lot tracking rather than Enfusion’s execution, compliance and institutional connectivity.", "choose_when": "Choose it for lower-cost portfolio analysis across Android, iOS, web and Windows without Enfusion’s order-management scope."}, {"ref": "sw:portfolio-performance", "name": "Portfolio Performance", "best_for": "Free multi-asset portfolio tracking across desktop platforms", "pricing": "Free plan", "key_difference": "Portfolio Performance provides free performance, allocation, risk and tax-lot analysis, without Enfusion’s execution, compliance or liquidity connectivity.", "choose_when": "Choose it when free portfolio analysis and tax-lot tracking matter more than Enfusion’s institutional trading workflows."}, {"ref": "sw:snowball-analytics", "name": "Snowball Analytics", "best_for": "Lower-cost multi-asset and alternative portfolio analysis", "pricing": "Free plan; paid from $7.99/user/mo; 14-day trial", "key_difference": "Snowball Analytics offers multi-asset and alternative-asset analysis at a lower entry price, without Enfusion’s OEMS and compliance functions.", "choose_when": "Choose it for affordable performance, allocation and risk analysis on Android, iOS and web."}, {"ref": "sw:qplix", "name": "QPLIX", "best_for": "Wealth managers needing accounting and branded client portals", "pricing": "Pricing on request", "key_difference": "QPLIX adds accounting, tax entries, CRM, multilingual reporting and branded client portals, while Enfusion centers investment operations and execution.", "choose_when": "Choose it when consolidated wealth management, automated accounting and client-facing access outweigh Enfusion’s trading infrastructure."}, {"ref": "sw:alternativesoft", "name": "AlternativeSoft", "best_for": "Alternative-asset analysis with advisor-facing platform access", "pricing": "Pricing on request", "key_difference": "AlternativeSoft emphasizes multi-asset and alternative-asset performance, allocation and risk analysis rather than Enfusion’s OEMS, compliance and liquidity connections.", "choose_when": "Choose it for alternative-asset analytics across API, Linux, macOS, web and Windows, with a free trial."}, {"ref": "sw:sharesight", "name": "Sharesight", "best_for": "Small portfolios needing inexpensive tracking and tax lots", "pricing": "Free plan; paid from $7/mo (annual); 14-day trial", "key_difference": "Sharesight offers multi-asset and alternative-asset tracking with tax-lot analysis, but its maximum is one portfolio and it lacks Enfusion’s execution stack.", "choose_when": "Choose it for a single portfolio and low-cost tracking on Android, iOS or web."}, {"ref": "sw:finary", "name": "Finary", "best_for": "Personal wealth tracking with alternative assets", "pricing": "Free plan; paid from €149.99/yr; 14-day trial", "key_difference": "Finary provides multi-asset and alternative-asset performance and allocation analysis, without Enfusion’s order execution, compliance and institutional risk tooling.", "choose_when": "Choose it for personal wealth analysis across Android, iOS, macOS and web at a freemium price."}]}